We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Growth Of Specialty Pharma Draws Generics Litigation

Law360 (December 3, 2007, 12:00 AM EST) -- As specialty pharmaceutical companies expand their foothold in the pharmaceutical arena, their drugs for niche markets are becoming much more susceptible to patent litigation with aggressive generics companies.

Specialty firms pick...
To view the full article, register now.